Reducing Time from Pediatric Emergency Department Arrival to Dexamethasone Administration in Wheezing Patients.

IF 1.2 Q3 PEDIATRICS Pediatric quality & safety Pub Date : 2024-06-11 eCollection Date: 2024-05-01 DOI:10.1097/pq9.0000000000000738
Andrew W Kramer, Jessica Erlich, Karen Yaphockun, Daniel Roderick, Kristen Farkas, Amy W Bryl, Kathryn H Pade
{"title":"Reducing Time from Pediatric Emergency Department Arrival to Dexamethasone Administration in Wheezing Patients.","authors":"Andrew W Kramer, Jessica Erlich, Karen Yaphockun, Daniel Roderick, Kristen Farkas, Amy W Bryl, Kathryn H Pade","doi":"10.1097/pq9.0000000000000738","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Asthma exacerbations are common presentations to pediatric emergency departments. Standard treatment for moderate-to-severe exacerbations includes administration of oral corticosteroids concurrently with bronchodilators. Early administration of corticosteroids has been shown to decrease emergency department length of stay (LOS) and hospitalizations. Our SMART aim was to reduce the time from arrival to oral corticosteroids (dexamethasone) administration in pediatric patients ≥2 years of age with an initial Pediatric Asthma Severity Score >6 from 60 to 30 minutes within 6 months.</p><p><strong>Methods: </strong>We used the model for improvement with collaboration between ED physicians, nursing, pharmacy, and respiratory therapists. Interventions included nursing education, dosage rounding in the electronic medical record, supplying triage with 1-mg tablets and a pill crusher, updates to an asthma nursing order set and pertinent chief complaints triggering nurses to document a Pediatric Asthma Severity Score in the electronic medical record and use the order set. Our primary outcome measure was the time from arrival to dexamethasone administration. Secondary outcome measures included ED LOS for discharged patients and admission rate. We used statistical process control to analyze changes in measures over time.</p><p><strong>Results: </strong>From October 2021 to March 2022, the average time for dexamethasone administration decreased from 59 to 38 minutes. ED LOS for discharged asthma exacerbation patients rose with overall ED LOS for all patients during the study period. There was no change in the admission rate.</p><p><strong>Conclusions: </strong>Using quality improvement methodology, we successfully decreased the time from ED arrival to administration of dexamethasone in asthma exacerbation patients from 59 to 38 minutes over 10 months.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167218/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric quality & safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/pq9.0000000000000738","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Asthma exacerbations are common presentations to pediatric emergency departments. Standard treatment for moderate-to-severe exacerbations includes administration of oral corticosteroids concurrently with bronchodilators. Early administration of corticosteroids has been shown to decrease emergency department length of stay (LOS) and hospitalizations. Our SMART aim was to reduce the time from arrival to oral corticosteroids (dexamethasone) administration in pediatric patients ≥2 years of age with an initial Pediatric Asthma Severity Score >6 from 60 to 30 minutes within 6 months.

Methods: We used the model for improvement with collaboration between ED physicians, nursing, pharmacy, and respiratory therapists. Interventions included nursing education, dosage rounding in the electronic medical record, supplying triage with 1-mg tablets and a pill crusher, updates to an asthma nursing order set and pertinent chief complaints triggering nurses to document a Pediatric Asthma Severity Score in the electronic medical record and use the order set. Our primary outcome measure was the time from arrival to dexamethasone administration. Secondary outcome measures included ED LOS for discharged patients and admission rate. We used statistical process control to analyze changes in measures over time.

Results: From October 2021 to March 2022, the average time for dexamethasone administration decreased from 59 to 38 minutes. ED LOS for discharged asthma exacerbation patients rose with overall ED LOS for all patients during the study period. There was no change in the admission rate.

Conclusions: Using quality improvement methodology, we successfully decreased the time from ED arrival to administration of dexamethasone in asthma exacerbation patients from 59 to 38 minutes over 10 months.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
缩短喘息患者从到达儿科急诊室到使用地塞米松的时间。
引言哮喘加重是儿科急诊的常见病。中度至重度哮喘加重的标准治疗方法包括在使用支气管扩张剂的同时口服皮质类固醇。事实证明,尽早使用皮质类固醇可缩短急诊科的住院时间(LOS)和住院次数。我们的 SMART 目标是在 6 个月内将初始小儿哮喘严重程度评分大于 6 分、年龄≥ 2 岁的儿科患者从到达医院到口服皮质类固醇(地塞米松)的时间从 60 分钟缩短至 30 分钟:我们采用了由急诊室医生、护理人员、药剂师和呼吸治疗师合作改进的模式。干预措施包括护理教育、在电子病历中记录用药剂量、为分诊人员提供 1 毫克药片和碎药机、更新哮喘护理医嘱集以及相关主诉,从而促使护士在电子病历中记录小儿哮喘严重程度评分并使用医嘱集。我们的主要结果指标是患者从到达医院到使用地塞米松的时间。次要结果指标包括出院患者的 ED LOS 和入院率。我们使用统计过程控制来分析各项指标随时间的变化:结果:从 2021 年 10 月到 2022 年 3 月,使用地塞米松的平均时间从 59 分钟缩短到 38 分钟。在研究期间,哮喘恶化出院患者的 ED LOS 与所有患者的总体 ED LOS 相比有所上升。入院率没有变化:通过采用质量改进方法,我们在 10 个月内成功地将哮喘加重患者从到达急诊室到使用地塞米松的时间从 59 分钟缩短至 38 分钟。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
审稿时长
20 weeks
期刊最新文献
Diagnostic Safety: Needs Assessment and Informed Curriculum at an Academic Children's Hospital. Implementing Screening for Neonatal Delirium in the Neonatal Intensive Care Unit: A Quality Improvement Initiative. Is Neonatal Delirium Ready for Prime Time Quality Improvement? Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative. A Quality Improvement Initiative to Reduce Duplicate Inflammatory Marker Use.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1